L. Dumont

Anti-L-selectin antibody treatment of hemorrhagic-traumatic shock in baboons.

H. Redl, G. Schlag, J. Davies, 1999, Critical care medicine.

The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53

V. Iotsova, C. Montpellier, S. Lottin, 1998, Oncogene.

H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression.

S. Lottin, E. Adriaenssens, A. Leprêtre, 1998, The American journal of pathology.

Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia.

D. Scheinberg, T. Deblasio, J. Jurcic, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.

D. Scheinberg, D A Scheinberg, P C Caron, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Radiolabeled F(ab′)2-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models

F. Brunotte, A. Cochet, J. Vrigneaud, 2018, Clinical and Translational Oncology.